ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Mechanisms of CNOT3 Tumor Suppression in T-ALL and Identification of New Drugs That Specifically Kill CNOT3-Deficient T-ALL Cells | Dana-Farber Cancer Institute / Zhaodong Li, PhD | Young Investigator Grants | 2014 | Massachusetts |
Therapies for SHH-subtype Medulloblastoma | Dana-Farber Cancer Institute / Rosalind Segal, M.D., Ph.D. | Innovation Grants | 2014 | Massachusetts |
Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing | University of Massachusetts Medical School / Peter Newburger, M.D. | Innovation Grants | 2014 | Massachusetts |
Development of a Screening Module to Assess Sibling-Related Psychosocial Risk in Families of Children with Cancer | Boston University / Kristin Long, PhD | Psychosocial Grants | 2014 | Massachusetts |
Understanding and Preventing Healthy Tissue Damage in Pediatric Cancer Patients | Dana-Farber Cancer Institute / Kristopher Sarosiek, PhD | Young Investigator Grants | 2014 | Massachusetts |
Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy | Dana-Farber Cancer Institute / Yana Pikman, MD | Young Investigator Grants | 2014 | Massachusetts |
Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma | Dana-Farber Cancer Institute / Thomas Look, M.D. | Innovation Grants | 2014 | Massachusetts |
Modeling the Multi-hit Pathogenesis of t(12;21) Associated Pediatric ALL by CRISPR/Cas-mediated Genome Engineering | Massachusetts General Hospital / Hanno Hock, M.D., Ph.D. | Innovation Grants | 2014 | Massachusetts |
Development of Targeted Leukemia Inhibitors Using Nanoparticle Delivery | University of Massachusetts Medical School / Lucio Castilla, Ph.D. | Innovation Grants | 2014 | Massachusetts |
DNA Methylation Inhibitor Therapy for Testicular Germ Cell Tumors | University of Illinois, Urbana-Champaign / Michael Spinella, Ph.D. | Reach Grants | 2014 | Illinois |